NCT05229055View on ClinicalTrials.gov

Intranasal Ketamine Versus Subcutaneous Ketamine for Treatment of Post-traumatic Acute Pain in the Emergency Department ( INVESCK )

PHASE2/PHASE3RecruitingINTERVENTIONAL

Enrollment

1,000

Participants

Timeline

Start Date

April 15, 2023

Primary Completion Date

May 30, 2024

Study Completion Date

December 1, 2025

Conditions

Acute Pain

Interventions

DRUG

Ketamine

giving ketamine intranasal

Trial Locations (1)

5000

RECRUITING

university of Monastir, Monastir

All Listed Sponsors

lead

University of Monastir

OTHER